MarleysDad's liver cancer is back.
The doctor wants to follow up the latest CT scan with a PET scan. Then, since this is apparently now inoperable, he's mentioned using a drug called Nexavar. I've been reading up on this, the bottom line being as follows:
Notice the survival times mentioned above. What I can't determine from the summaries I've found is what stage the cancer was in the study patients. I presume, if they had later stage cancers, the survival time would be shorter than for those with an earlier stage. The CT scan report MarleysDad sent me doesn't specify, but it looks like he'd now be considered to have Stage II.Treatment with Nexavar has been shown to increase overall survival in patients with unresectable HCC. In a large study of 602 patients, Nexavar increased survival time (10.7 months with Nexavar vs 7.9 months with placebo) and the time until the tumor progressed or grew (5.5 months with Nexavar vs 2.8 months with placebo). This was the first time any therapy was proven to extend survival in patients with unresectable HCC. As a result, Nexavar became the first medication to be approved by the FDA for the treatment of patients with unresectable HCC.
In this same study, Nexavar was generally well tolerated by patients, but some serious side effects occurred. The most common side effects associated with Nexavar were diarrhea, fatigue, abdominal pain, weight loss, anorexia, nausea, hand-foot skin reaction, and rash/desquamation.
Comments?